Of interest was the observation that the change in CSF neurofilament heavy chain from baseline to three weeks was a predictor of the subsequent clinical outcome in the MS but not of the optic neuritis group.[63] Of interest is also the observation that antibodies to neurofilaments occur in the serum and CSF of patients with MS. This evidence concerns the gene SLC3A2 and myeloid sarcoma.